title: Costs and consequences of botulinum toxin type A use. Management of children with cerebral palsy in Germany.
abstract: This study was a retrospective survey of the management of a cohort of children with cerebral palsy at Seepark Hospital, Germany, who did (cases; n=107) and did not (controls; n=107) receive botulinum toxin injections. Data on healthcare resource use and clinical outcomes over 12 months were collected from the date cases received their first injection and from the date controls were first admitted into hospital. Botulinum toxin use led to an 85% reduction in the number of children requiring surgery. Additionally, controls used significantly more healthcare resources than cases, particularly hospital bed days (69.2+/-34.1 vs. 27.5+/-27.9 days; p <0.0001). The total cost of managing cases and controls was <euro>16,700 and <euro>33,800, respectively. In conclusion, use of botulinum toxin released resources for alternative use during the first year following treatment, without any loss of clinical improvement. However, it is unknown how botulinum toxin affected the need for surgery and associated outcomes in subsequent years.
authors.affiliation: Catalyst Health Economics Consultants, Northwood, Middlesex, UK.
authors.forename: Francis J
authors.initials: FJ
authors.lastname: Ruiz
authors.forename: Julian F
authors.initials: JF
authors.lastname: Guest
authors.forename: Almut
authors.initials: A
authors.lastname: Lehmann
authors.forename: Alison M
authors.initials: AM
authors.lastname: Davie
authors.forename: Karen
authors.initials: K
authors.lastname: Güttler
authors.forename: Olaf
authors.initials: O
authors.lastname: Schlüter
authors.forename: Götz
authors.initials: G
authors.lastname: Dreiss
mesh_terms: D000293:Adolescent; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy* / Q000191:economics* / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D003365:Costs and Cost Analysis; D005260:Female; D005858:Germany; D006295:Health Resources / Q000706:statistics & numerical data; D006801:Humans; D007902:Length of Stay; D008297:Male; D015999:Multivariate Analysis; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D018579:Patient Selection; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A
references.citation: Am J Phys Med Rehabil. 2003 Apr;82(4):284-9
references.pmid: 12649654
references.citation: J Pediatr Orthop. 1987 May-Jun;7(3):256-8
references.pmid: 3584438
references.citation: Clin Orthop Relat Res. 1996 Feb;(323):254-60
references.pmid: 8625589
references.citation: J Paediatr Child Health. 1995 Feb;31(1):24-8
references.pmid: 7748684
references.citation: J Paediatr Child Health. 2003 Jan-Feb;39(1):6-14
references.pmid: 12542805
references.citation: Rev Esp Salud Publica. 2000 Sep-Dec;74(5-6):549-59
references.pmid: 11217244
references.citation: Int Orthop. 1992;16(3):291-3
references.pmid: 1428346
references.citation: Clin Orthop Relat Res. 2002 Jan;(394):177-85
references.pmid: 11795730
references.citation: Eur J Neurol. 2001 Nov;8 Suppl 5:145-9
references.pmid: 11851743
references.citation: Gait Posture. 2000 Feb;11(1):67-79
references.pmid: 10664488
references.citation: Arch Phys Med Rehabil. 1977 Apr;58(4):154-7
references.pmid: 849129
references.citation: Med J Aust. 2003 Jan 20;178(2):95-6; author reply 96
references.pmid: 12526736
references.citation: Arch Phys Med Rehabil. 1996 Jul;77(7):717-21
references.pmid: 8670002
references.citation: Int J Clin Pract. 2002 Oct;56(8):564-7
references.pmid: 12425363
references.citation: Acta Neurol Scand. 1995 Jun;91(6):423-32
references.pmid: 7572035
references.citation: Arch Phys Med Rehabil. 2003 Mar;84(3):444-54
references.pmid: 12638115
references.citation: Clin J Pain. 2002 Nov-Dec;18(6 Suppl):S182-90
references.pmid: 12569967
references.citation: J Pediatr Orthop. 1987 May-Jun;7(3):253-5
references.pmid: 3584437
references.citation: Curr Opin Pediatr. 1997 Feb;9(1):81-8
references.pmid: 9088760
references.citation: Eur J Neurol. 2001 Nov;8 Suppl 5:1-20
references.pmid: 11851730
references.citation: Dev Med Child Neurol. 2002 Dec;44(12):820-7
references.pmid: 12455858
references.citation: Clin Orthop Relat Res. 1966 May-Jun;46:7-22
references.pmid: 5950310
references.citation: Arch Dis Child Fetal Neonatal Ed. 1998 Jul;79(1):F21-5
references.pmid: 9797620
references.citation: J Pediatr Orthop. 1992 May-Jun;12(3):329-36
references.pmid: 1572996
references.citation: Phys Ther. 1988 Dec;68(12):1903-12
references.pmid: 3057525
references.citation: J Child Neurol. 1996 Mar;11(2):77-83
references.pmid: 8881981
references.citation: Int Orthop. 1993;17(3):162-5
references.pmid: 8340171
references.citation: Eur J Neurol. 2001 Nov;8 Suppl 5:183-93
references.pmid: 11851747
references.citation: W V Med J. 1994 May;90(5):190-2
references.pmid: 8053168
references.citation: Pediatrics. 2001 Nov;108(5):1062-71
references.pmid: 11694682
references.citation: Eur J Neurol. 2001 Nov;8 Suppl 5:194-202
references.pmid: 11851748
references.citation: J Child Neurol. 1996 Mar;11(2):75-76
references.pmid: 8881980
references.citation: Brain Dev. 1994 Nov-Dec;16(6):423-31
references.pmid: 7694988
references.citation: Neurology. 1994 Nov;44(11 Suppl 9):S60-8; discussion S68-9
references.pmid: 7970013
references.citation: Proc R Soc Med. 1970 Sep;63(9):937-8
references.pmid: 5477077